Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2- ICG in a Phase 1 Clinical Trial

NCT07438860 is registered in ClinicalTrials.gov with Tiffany Hodges as lead sponsor.

NCT NCT07438860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07438860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2- ICG in a Phase 1 Clinical Trial
Lead sponsor
Tiffany Hodges
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 2, 2026
Completion date
December 31, 2027
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, malignant brain tumors